Skip Navigation

Mark Mulligan, MD

Professor
Emory Vaccine Center

Director
Hope Clinic of the Emory Vaccine Center

Professor
Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine

Investigator
Emory Center for AIDS Research

Phone: 404-712-9046

Fax: 404-370-6142

Email: mark.mulligan@emory.edu

Mark J. Mulligan, MD is a Professor of Medicine within the Division of Infectious Diseases at Emory University.  He is the Associate Division Director for Clinical and Translational Research, Division of Infectious Diseases, and the Associate Director for Clinical Trials at the Emory Vaccine Center.  Dr. Mulligan serves as the Executive Director of The Hope Clinic of the Emory Vaccine Center.  The Hope Clinic, the clinical arm of the Emory Vaccine Center, is focused on clinical trials of vaccines and other prevention technologies, human translational immunology studies, education, and training the next generation of vaccine researchers.  Dr. Mulligan also serves as Co-Director of the Clinical Core of the Emory Center for AIDS Research (CFAR).  He directs the NIAID-sponsored Emory HIV Vaccine Trials Unit (HVTU) and is principal investigator for the NIAID-sponsored Emory Vaccine and Treatment Evaluation Unit (VTEU).  He is an international leader in clinical trials of HIV vaccines, having held several leadership positions in the HVTN.  Since 2009 he has directed the Emory Vaccinology Training Program, a MD or PhD postdoctoral fellow training program funded by a NIH T32 award. The following are the links to these program websites:

Research Interests

Mark J. Mulligan, MD is a Professor of Medicine within the Division of Infectious Diseases at Emory University.  He is the Associate Division Director for Clinical and Translational Research, Division of Infectious Diseases, and the Associate Director for Clinical Trials at the Emory Vaccine Center.  Dr. Mulligan serves as the Executive Director of The Hope Clinic of the Emory Vaccine Center.  The Hope Clinic, the clinical arm of the Emory Vaccine Center, is focused on clinical trials of vaccines and other prevention technologies, human translational immunology studies, education, and training the next generation of vaccine researchers.  Dr. Mulligan also serves as Co-Director of the Clinical Core of the Emory Center for AIDS Research (CFAR).  He directs the NIAID-sponsored Emory HIV Vaccine Trials Unit (HVTU) and is principal investigator for the NIAID-sponsored Emory Vaccine and Treatment Evaluation Unit (VTEU).  He is an international leader in clinical trials of HIV vaccines, having held several leadership positions in the HVTN.  Since 2009 he has directed the Emory Vaccinology Training Program, a MD or PhD postdoctoral fellow training program funded by a NIH T32 award.

After college at the University of Notre Dame (B.S. with honors, pre-professional studies, 1980), he attended the University of Texas Southwestern Medical School in Dallas (M.D., 1984).  He then completed an internal medicine residency at the University of Alabama at Birmingham (UAB) (1987), and remained at UAB for his infectious diseases fellowship (1987-90).  Dr. Mulligan received molecular virology training (1987-90) as a postdoctoral fellow in Dr. Richard Compans’ laboratory at UAB and was supported by a NIH K11 Physician-Scientist Award (1988-1993).  After joining the infectious diseases faculty at UAB in 1990, he was awarded a NIH RO1 for his molecular virology studies.  By 1994, Dr. Mulligan had broadened his scientific interests to vaccines and T cell immunology.

Publications